Estimating the safe starting dose in phase I clinical...

Regulatory Toxicology and Pharmacology 2004 Vol. 40; Iss. 3

Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily dose

Joseph F. Contrera, Edwin J. Matthews, Naomi L. Kruhlak, R. Daniel Benz
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
40
Year:
2004
Language:
english
DOI:
10.1016/j.yrtph.2004.08.004
File:
PDF, 491 KB
english, 2004
Conversion to is in progress
Conversion to is failed